SONOMA PHARMACEUTICALS, INC. Deferred Income Tax Assets, Net
SONOMA PHARMACEUTICALS, INC. (SNOA) had Deferred Income Tax Assets, Net of $905.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-08-06
- 2026-06-30: Deferred Income Tax Assets, Net $905.00K.
- 2026-03-31: Deferred Income Tax Assets, Net $884.00K.
- 2025-12-31: Deferred Income Tax Assets, Net $458.00K.
- 2025-09-30: Deferred Income Tax Assets, Net $508.00K.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2026-06-30 | $905.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $884.00K 10-Q · filed 2026-08-06 |
| 2025-12-31 | $458.00K 10-Q · filed 2026-02-10 |
| 2025-09-30 | $508.00K 10-Q · filed 2025-11-04 |
| 2025-06-30 | $546.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $589.00K 10-K · filed 2026-06-16 |
| 2024-12-31 | $760.00K 10-Q · filed 2025-02-05 |
| 2024-09-30 | $792.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $921.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.15M 10-K · filed 2025-06-17 |
| 2023-12-31 | $922.00K 10-Q · filed 2024-02-08 |
| 2023-09-30 | $840.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $908.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $949.00K 10-K · filed 2024-06-17 |
| 2022-12-31 | $1.09M 10-Q · filed 2023-02-14 |
| 2022-09-30 | $957.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $859.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $829.00K 10-K · filed 2023-06-21 |
| 2021-03-31 | $0.00 10-K · filed 2022-07-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |